Live Breaking News & Updates on Boehringer Ingelheim Us Corp
Stay updated with breaking news from Boehringer ingelheim us corp . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After more than a decade of industry pleading for guidance on Orange Book patent listings, the U.S. FDA is finally planning on answering that request this year. If the guidance that’s produced reflects the FTC’s position that device patents can’t be listed for combination products, it could overturn years of accepted practice and possibly hinder the development of new, more advanced drug administration technologies. ....